Insider Stock Trading History of Simon Robert L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Simon Robert L since year 2005. The trader's CIK number is 1220050. At the time of this reporting, Simon Robert L is the Exec. VP, Pharm. Dev of Osi Pharmaceuticals Inc . (stock ticker symbol OSIP). See this page for all insider trading activities at Osi Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Simon Robert L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-02-03 OSIP Osi Pharmaceuticals Inc Sale 3,401 41.25 140,291
2009-02-03 OSIP Osi Pharmaceuticals Inc Option Ex 3,401 21.55 73,291
2009-01-06 OSIP Osi Pharmaceuticals Inc Sale 49 40.00 1,960
2009-01-06 OSIP Osi Pharmaceuticals Inc Option Ex 49 21.55 1,055
2008-11-07 OSIP Osi Pharmaceuticals Inc Option Ex 1,150 21.55 24,782
2008-11-07 OSIP Osi Pharmaceuticals Inc Sale 1,150 41.59 47,828
2008-10-01 OSIP Osi Pharmaceuticals Inc Option Ex 1,150 21.55 24,782
2008-10-01 OSIP Osi Pharmaceuticals Inc Sale 1,150 48.70 56,005
2008-09-02 OSIP Osi Pharmaceuticals Inc Sale 1,150 50.42 57,983
2008-09-02 OSIP Osi Pharmaceuticals Inc Option Ex 1,150 21.55 24,782
2008-08-01 OSIP Osi Pharmaceuticals Inc Option Ex 1,150 21.55 24,782
2008-08-01 OSIP Osi Pharmaceuticals Inc Sale 1,150 52.27 60,110
2008-07-01 OSIP Osi Pharmaceuticals Inc Option Ex 1,150 21.55 24,782
2008-07-01 OSIP Osi Pharmaceuticals Inc Sale 1,150 41.32 47,518
2008-06-05 OSIP Osi Pharmaceuticals Inc Option Ex 2,300 21.50 49,450
2008-06-05 OSIP Osi Pharmaceuticals Inc Sale 2,300 40.00 92,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Simon Robert L (Exec. VP, Pharm. Dev of Osi Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.